[May 31, 2022 – Washington, DC] At a time when hospitals are under unprecedented logistical and financial strain, a new industry-wide report illuminates the potential for saving money and reducing waste and emissions by extending the life of “single-use” medical devices through reprocessing. The U.S. Food and Drug Administration regulates the commercial reprocessing industry to assure that devices are as safe and effective as original devices.
The report was compiled from data collected from members of the Association of Medical Device Reprocessors (AMDR), the global trade association representing the interests of the professional medical device reprocessing industry.
According to the report, reprocessing saved U.S. hospitals $372 million in 2020, because using reprocessed devices cost 25 to 40% less and the reduction in medical waste offers further savings. Furthermore, AMDR data indicates that if the reprocessing practices of the top-10% performing hospitals were emulated across all hospitals that use reprocessed devices, the U.S. hospitals could have saved an additional $2.28 billion in 2020. This analysis is based only on existing product offerings and practices so this number could be larger if more products are reprocessed. . .